Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$4.82 - $9.15 $137,774 - $261,543
-28,584 Reduced 30.79%
64,255 $406,000
Q1 2024

May 15, 2024

BUY
$3.23 - $6.17 $299,869 - $572,816
92,839 New
92,839 $498,000
Q2 2022

Aug 15, 2022

SELL
$2.68 - $6.14 $30,066 - $68,884
-11,219 Closed
0 $0
Q1 2022

May 20, 2022

BUY
$5.05 - $7.53 $56,655 - $84,479
11,219 New
11,219 $63,000

Others Institutions Holding IBRX

About ImmunityBio, Inc.


  • Ticker IBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 400,304,000
  • Market Cap $1.38B
  • Description
  • ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...
More about IBRX
Track This Portfolio

Track Toroso Investments, LLC Portfolio

Follow Toroso Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Toroso Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Toroso Investments, LLC with notifications on news.